Home > Boards > US Listed > Biotechs >

ImmunoCellular Therapeutics, Ltd. (IMUC)

Add IMUC Price Alert      Hide Sticky   Hide Intro
Moderator: hotrod34racer
Search This Board: 
Last Post: 4/18/2018 2:27:07 PM - Followers: 195 - Board type: Free - Posts Today: 0




ImmunoCellular Therapeutics continues to make significant progress in meeting important goals and positioning the company for success. We believe that our cancer vaccine platform has the potential to be transformative in the treatment of cancer, and to create value for all our stakeholders. Our goal is to build ImmunoCellular into a leading, independent commercial-stage cancer immunotherapy company.

Our dendritic cell (DC) vaccine technology and advanced manufacturing offer several advantages over earlier-generation cellular immunotherapies:

- Matured DCs secrete IL12, which is critical for stimulating T cell killing of cancer cells.
More than 80% of the final manufactured product consists of matured DCs.

- Unlike other cell-based vaccines, our DCs target multiple antigens, thus increasing the likelihood of effective treatment.

- Advanced manufacturing enables production of at least 20 doses of vaccine from a single apheresis (blood collection); thus patients do not need to undergo additional apheresis procedures.

- Compared to the only approved cell-based immunotherapy, our DC vaccines can be manufactured at a significantly reduced cost.

- Ability to freeze and store vaccine for months or years eliminates the need to administer to the patient shortly after manufacture.
- Intradermal administration route reduces the time and inconvenience of intravenous infusion for both patient and physician.

Company Information:

21900 Burbank, 3rd Floor
Woodland Hills, CA 91367

Phone: 818-992-2907 



Press Releases:



Transfer Agent:

U.S. Stock Transfer Corp.
Suite 200
Glendale, CA 91204-2991

 Investor Relations:

Gary Nash, CEOcast, Inc.

Tel: (212)732-4300




ImmunoCellular has concluded a phase II trial of its lead product candidate, ICT-107, a dendritic cell-based vaccine targeting multiple tumor-associated antigens for glioblastoma. ImmunoCellular's pipeline also includes: ICT-121, a dendritic cell vaccine targeting CD133; ICT-140, a dendritic cell vaccine targeting ovarian cancer antigens and cancer stem cells; and the Stem-to-T-cell research program which engineers the patient's hematopoietic stem cells to generate antigen-specific cancer killing T-cells.

Announced the establishment of an agreement with PharmaCell B.V. to provide contract manufacturing services for the European production of ICT-107, a dendritic cell-based cancer immunotherapy in development as a potential treatment for glioblastoma (GBM). This agreement with PharmaCell, a leading European contract manufacturing organization focuses on the production of human cell therapy products, and is designed to enable ImmunoCellular to access phase 3 supplies of ICT-107, manufactured with ImmunoCellular's commercial-ready production process. ImmunoCellular intends to initiate a Phase 3 registrational program for ICT-107 in the US and in Europe in 2015

>>> What these CANCER vaccines could be worth


Investor Presentation -> 





Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
IMUC News: ImmunoCellular Therapeutics Announces Achievement of Next Key Milestone in Stem-to-T-Cell Research Immuno-Oncology Program 04/12/2018 06:00:00 AM
IMUC News: ImmunoCellular Therapeutics Receives Audit Opinion with Going Concern Explanation 03/26/2018 06:00:00 AM
IMUC News: Annual Report (10-k) 03/14/2018 05:26:59 PM
IMUC News: Current Report Filing (8-k) 03/13/2018 04:43:41 PM
IMUC News: ImmunoCellular Therapeutics Announces Fourth Quarter and Full Year 2017 Financial Results 03/13/2018 04:05:00 PM
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
#5260   I like that forecast. SamuelPro 04/18/18 02:27:07 PM
#5259   Going higher! PyschoNoobStock 04/18/18 01:21:16 PM
#5258   Weeee!!!!!!! PyschoNoobStock 04/18/18 01:00:43 PM
#5257   Reversal? Dmwcrash 04/18/18 12:44:20 PM
#5256   Found this stock price forecast for IMUC, it nofortunateson2 04/14/18 05:38:22 PM
#5255   yeah, with this shorting nowadays, trading apps in Trompete 04/14/18 11:14:45 AM
#5254   Whenever clay trader appears expect it to return Hbpainter 04/14/18 05:28:23 AM
#5253   I’ve heard that before Lion33 04/12/18 05:47:45 PM
#5252   * * $IMUC Video Chart 04-12-18 * * ClayTrader 04/12/18 05:02:33 PM
#5251   Sorry guys but I jumped ship at the top. Dmwcrash 04/12/18 11:45:33 AM
#5250   Anything under .30 is a steal Joecanada13 04/12/18 10:19:50 AM
#5249   Up .32! PyschoNoobStock 04/12/18 09:53:10 AM
#5248   BIG NEWS!! PyschoNoobStock 04/12/18 09:49:40 AM
#5247   BIG NEWS!!! PyschoNoobStock 04/12/18 09:49:16 AM
#5246   ImmunoCellular Therapeutics Successfully Transfers T Cell Receptor Genetic PyschoNoobStock 04/12/18 09:48:08 AM
#5245   BRIEF-Immunocellular Therapeutics Announces Achievement Of Next Key Milestone PyschoNoobStock 04/12/18 09:47:43 AM
#5244   ImmunoCellular: Milestone Represents Next Important Step in Validating PyschoNoobStock 04/12/18 09:47:11 AM
#5243   ImmunoCellular Able to Verify Successful Transfer of the PyschoNoobStock 04/12/18 09:46:52 AM
#5242   ImmunoCellular Therapeutics Announces Achievement of Next Key Milestone PyschoNoobStock 04/12/18 09:46:21 AM
#5241   Nice news!!! Joecanada13 04/12/18 09:40:54 AM
#5240   BOOM! PyschoNoobStock 04/12/18 09:34:34 AM
#5239   Do you guys have any clue of how Virgilio 04/02/18 04:01:55 AM
#5238   Clearing out the guys selling for beer money Dmwcrash 03/28/18 03:21:41 PM
#5237   It's almost slap time Dmwcrash 03/19/18 12:48:20 PM
#5236   Individualized treatment/medicine is a growing concept. Still tons JPL1868 03/15/18 10:56:57 AM
#5235   Well, we have come down to test the Dmwcrash 03/15/18 10:52:23 AM
#5234   Nice bump!!! What a POS this has become, Lion33 03/14/18 11:51:40 AM
#5233   I'm sick of the bleeding. I'm out. Upset Wookie 03/14/18 11:26:27 AM
#5232   ImmunoCellular Therapeutics Q4 Loss Narrows Sharply - Stock PyschoNoobStock 03/13/18 09:35:27 PM
#5231   Bump tomorrow. Wow. JPL1868 03/13/18 04:52:13 PM
#5230   Better than I anticipated. Might see a nice JPL1868 03/13/18 04:51:49 PM
#5229   ImmunoCellular Therapeutics Announces Fourth Quarter and Full Year NYK PT 03/13/18 04:28:24 PM
#5228   But has been bouncing back everytime. People are Dmwcrash 03/13/18 02:06:02 AM
#5227   There it go.. Broke new low.. PyschoNoobStock 03/12/18 10:15:25 AM
#5226   Well. Look like we are going see new PyschoNoobStock 03/12/18 10:14:34 AM
#5225   .33 broken.. UP we go! PyschoNoobStock 03/12/18 09:33:37 AM
#5224   Could go up quickly sindram 03/10/18 06:53:07 AM
#5223   Next week will be interesting ... NYK PT 03/09/18 03:23:05 PM
#5222   It’s coming. Another JA*X perhaps. JPL1868 03/09/18 03:21:30 PM
#5221   Ya think we going boom? PyschoNoobStock 03/09/18 03:20:20 PM
#5220   Boom.. PyschoNoobStock 03/09/18 03:16:44 PM
#5219   No clue.. PyschoNoobStock 03/08/18 09:34:35 AM
#5218   Hitting.. PyschoNoobStock 03/08/18 09:34:10 AM
#5217   Where are we going to stop? NYK PT 03/07/18 01:11:03 PM
#5216   Here we go.. Heading up! PyschoNoobStock 03/07/18 01:06:19 PM
#5215   IMUC buy 0.3084 stocktrademan 03/07/18 11:26:15 AM
#5214   At least there’s strong bid support here JPL1868 03/07/18 10:55:26 AM
#5213   EOM shorty cover Dmwcrash 03/07/18 10:52:05 AM
#5212   My order at the ask wasn't filled. Something Upset Wookie 03/07/18 09:23:59 AM
#5211   UP .36! PyschoNoobStock 03/07/18 09:20:51 AM